Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography

Osnat Itzhaki Ben Zadok1, Alon Eisen1, Yaron Shapira1

  • 1Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Insights

Early echocardiography can detect cardiac amyloidosis (CA) years before diagnosis. Key findings include increased wall thickness and diastolic dysfunction, aiding in earlier detection of CA, particularly the amyloid transthyretin (ATTR) subtype.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac Amyloidosis

Background:

  • Cardiac amyloidosis (CA) diagnosis is often delayed, leading to echocardiographic findings of advanced cardiomyopathy.
  • Early detection of CA is crucial for timely intervention and improved patient outcomes.

Purpose of the Study:

  • To identify and describe early echocardiographic features in patients later diagnosed with CA.
  • To stratify these early findings based on CA pathogenetic subtype (AL or ATTR).

Main Methods:

  • Screening of pre-amyloid diagnosis echocardiographic studies for structural and functional parameters.
  • Stratification of echocardiographic abnormalities by immunoglobulin light-chain (AL) and amyloid transthyretin (ATTR) subtypes.
  • Analysis of 42 earlier echocardiography exams from a cohort of 75 CA patients.

Main Results:

  • Increased wall thickness was observed ≥3 years prediagnosis, and increased relative wall thickness ≥7 years prediagnosis.
  • Restrictive left ventricular (LV) filling patterns and reduced LV ejection fraction (≤50%) were present 1-3 years before diagnosis.
  • ATTR-CA showed significantly increased relative wall thickness and LV mass index, and reduced LV ejection fraction compared to AL-CA.

Conclusions:

  • Early echocardiographic signs of CA, including increased wall thickness and diastolic dysfunction, develop years before clinical diagnosis.
  • Standard echocardiography can identify these abnormalities in earlier stages, facilitating earlier CA diagnosis and management.
  • Distinct echocardiographic phenotypes exist between ATTR-CA and AL-CA, offering potential for subtype differentiation.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
123
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
242
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
295
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
252
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
288